Dr. Cheryl R. Blanchard Ph.D.Anika Therapeutics
Cheryl Blanchard, Ph.D. joined the Board of Directors of Anika Therapeutics in August 2018. On April 26, 2020, Dr. Blanchard was appointed President and Chief Executive Officer of Anika Therapeutics, after serving as interim Chief Executive Officer since February 2020. Prior to her work as an executive officer with Anika, she served as the President and Chief Executive Officer of Microchips Biotech, Inc., a venture-backed biotechnology company developing regenerative medicine and drug delivery products, from 2014 until its sale to Daré Bioscience, Inc. in November 2019. From 2012 to 2020, Dr. Blanchard has also been a Principal at Blanchard Consulting, LLC which provides scientific, regulatory, and business strategy consulting services to medical device companies and private equity clients.
Year appointed: 2020